The Trump administration is facing conflicting political pressures after Health Secretary Robert F. Kennedy Jr. said the Food and Drug Administration will "study" adding safety restrictions on ...

The Food and Drug Administration will review evidence about the safety and efficacy of the abortion drug Mifepristone.

Currently, telehealth accounts for a quarter of abortions in the U.S., and in 2023, nearly two-thirds of abortions were done ...

The Trump administration said it will review the medication abortion drug mifepristone (Mifeprex) to see whether current ...

Wyoming Attorney General Keith Kautz said he joined 21 other states in asking the FDA to investigate an abortion-inducing ...

HHS and FDA launch review of abortion pill mifepristone after disputed safety study, sparking backlash from abortion rights advocates.

Mifepristone is the primary way abortions continue in states with bans, because it can be prescribed and sent via telehealth.

Health and Human Services Secretary Robert F. Kennedy Jr. has launched a Food and Drug Administration review of mifepristone, a pill used in nearly two-thirds of abortions across the U.S.

The US Food and Drug Administration will review evidence about the safety and efficacy of mifepristone, one of the drugs used ...

Kennedy Jr. announced this week that the FDA will launch a fresh review of mifepristone, the primary drug used for medication ...

Health and Human Services Secretary Robert F. Kennedy Jr. told Republican states this week that the FDA would conduct a new ...

The Trump administration is reviewing the safety protocols surrounding the abortion pill mifepristone as conservative states ...